Locally Advanced Head and Neck Squamous Cell Carcinoma Clinical Trials in London, Ontario
2 recruitingLondon, Ontario, Canada
Showing 1–2 of 2 trials
Recruiting
Phase 3
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
AstraZeneca1,145 enrolled305 locationsNCT06129864
Recruiting
Not Applicable
Low-Dose Weekly vs High-Dose Cisplatin
Locally Advanced Head and Neck Squamous Cell Carcinoma
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's100 enrolled3 locationsNCT03649048